Rhumbline Advisers Connect Biopharma Holdings LTD Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Rhumbline Advisers holds 2,370 shares of CNTB stock, worth $1,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,370
Previous 9,500
75.05%
Holding current value
$1,753
Previous $11,000
90.91%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CNTB
# of Institutions
16Shares Held
3.23MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.55 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$377,9180.04% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$119,0410.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$99,6750.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$76,8790.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $40.7M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...